The impact of HLA class I and EBV latency-II antigen-specific CD8( ) T cells on the pathogenesis of EBV Hodgkin lymphoma
K Jones, L Wockner, RM Brennan, C Keane, PK Chattopadhyay, M Roederer, DA Price, DK Cole, B Hassan, K Beck, D Gottlieb, DS Ritchie, JF Seymour, F Vari, P Crooks, SR Burrows, MK Gandhi
Clinical & Experimental Immunology | WILEY | Published : 2016
This study was conducted under the auspices of the Australasian Leukaemia and Lymphoma Group. K. J. and C. K. were supported by the Leukaemia Foundation (Australia). M. K. G. is supported by the Leukaemia Foundation of Queensland. D. A. P. is a Wellcome Trust Senior Investigator. S. R. B is an NHMRC Principal Research Fellow (APP1021452).